Thermo Fisher Scientific Inc. (TMO) Stake Raised by Abner Herrman & Brock LLC

Abner Herrman & Brock LLC grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,260 shares of the medical research company’s stock after buying an additional 1,632 shares during the period. Thermo Fisher Scientific accounts for about 1.6% of Abner Herrman & Brock LLC’s investment portfolio, making the stock its 29th largest position. Abner Herrman & Brock LLC’s holdings in Thermo Fisher Scientific were worth $8,562,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in TMO. Cornerstone Advisors Inc. boosted its stake in shares of Thermo Fisher Scientific by 33.3% during the third quarter. Cornerstone Advisors Inc. now owns 332 shares of the medical research company’s stock valued at $81,000 after purchasing an additional 83 shares during the period. Private Trust Co. NA boosted its stake in shares of Thermo Fisher Scientific by 7.9% during the fourth quarter. Private Trust Co. NA now owns 1,730 shares of the medical research company’s stock valued at $387,000 after purchasing an additional 127 shares during the period. Fulton Bank N.A. boosted its stake in shares of Thermo Fisher Scientific by 3.6% during the fourth quarter. Fulton Bank N.A. now owns 4,185 shares of the medical research company’s stock valued at $937,000 after purchasing an additional 145 shares during the period. Rehmann Capital Advisory Group boosted its stake in shares of Thermo Fisher Scientific by 5.6% during the third quarter. Rehmann Capital Advisory Group now owns 3,288 shares of the medical research company’s stock valued at $803,000 after purchasing an additional 173 shares during the period. Finally, WealthPLAN Partners LLC boosted its stake in shares of Thermo Fisher Scientific by 8.3% during the third quarter. WealthPLAN Partners LLC now owns 2,488 shares of the medical research company’s stock valued at $581,000 after purchasing an additional 190 shares during the period. Hedge funds and other institutional investors own 86.92% of the company’s stock.

A number of analysts have recently issued reports on TMO shares. UBS Group started coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, October 9th. They set a “buy” rating and a $295.00 target price for the company. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $274.00 target price for the company in a research note on Monday, October 1st. Goldman Sachs Group lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Monday, September 17th. Morgan Stanley boosted their target price on shares of Thermo Fisher Scientific from $242.00 to $254.00 and gave the company an “overweight” rating in a research note on Wednesday, October 10th. Finally, Cleveland Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Thursday, October 18th. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $271.10.



NYSE:TMO traded down $1.23 during mid-day trading on Friday, reaching $237.63. The company’s stock had a trading volume of 24,994 shares, compared to its average volume of 2,140,164. Thermo Fisher Scientific Inc. has a 1 year low of $194.51 and a 1 year high of $253.91. The firm has a market cap of $95.17 billion, a PE ratio of 25.08, a price-to-earnings-growth ratio of 1.54 and a beta of 1.08. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.84 and a quick ratio of 1.27.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 24th. The medical research company reported $2.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.55 by $0.07. Thermo Fisher Scientific had a net margin of 10.75% and a return on equity of 16.49%. The company had revenue of $5.92 billion during the quarter, compared to analyst estimates of $5.70 billion. During the same period in the prior year, the firm earned $2.31 earnings per share. The firm’s revenue for the quarter was up 15.7% compared to the same quarter last year. Sell-side analysts anticipate that Thermo Fisher Scientific Inc. will post 11.05 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Shareholders of record on Monday, December 17th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Friday, December 14th. This represents a $0.68 dividend on an annualized basis and a yield of 0.29%. Thermo Fisher Scientific’s dividend payout ratio is presently 7.17%.

In other Thermo Fisher Scientific news, insider Gregory J. Herrema sold 17,235 shares of the business’s stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $247.00, for a total value of $4,257,045.00. Following the completion of the transaction, the insider now directly owns 26,446 shares in the company, valued at $6,532,162. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Tyler Jacks sold 4,772 shares of the business’s stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $239.75, for a total transaction of $1,144,087.00. The disclosure for this sale can be found here. Insiders sold 32,607 shares of company stock valued at $7,972,085 over the last quarter. 0.49% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Thermo Fisher Scientific Inc. (TMO) Stake Raised by Abner Herrman & Brock LLC” was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://dakotafinancialnews.com/2019/01/11/thermo-fisher-scientific-inc-tmo-stake-raised-by-abner-herrman-brock-llc.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: How much can an individual set aside as a catch-up contribution?

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply